AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 162 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $661,000 | +30.1% | 22,400 | +197.7% | 0.32% | +57.4% |
| Q2 2018 | $508,000 | -60.2% | 7,525 | -68.0% | 0.20% | -57.7% |
| Q1 2018 | $1,275,000 | -9.3% | 23,519 | 0.0% | 0.48% | -6.3% |
| Q4 2017 | $1,405,000 | +16.6% | 23,519 | -5.2% | 0.51% | +4.7% |
| Q3 2017 | $1,205,000 | -14.1% | 24,800 | -7.1% | 0.49% | -19.1% |
| Q2 2017 | $1,403,000 | -45.8% | 26,700 | -53.2% | 0.60% | -48.3% |
| Q1 2017 | $2,589,000 | -1.6% | 57,100 | -17.9% | 1.16% | -5.1% |
| Q4 2016 | $2,631,000 | -5.7% | 69,525 | -6.0% | 1.23% | +42.2% |
| Q3 2016 | $2,791,000 | +45.4% | 73,975 | -32.2% | 0.86% | -10.3% |
| Q2 2016 | $1,919,000 | +40.3% | 109,050 | -3.1% | 0.96% | +44.9% |
| Q1 2016 | $1,368,000 | -52.6% | 112,500 | -5.0% | 0.66% | -41.8% |
| Q4 2015 | $2,884,000 | +33.5% | 118,450 | -2.8% | 1.14% | +32.1% |
| Q3 2015 | $2,161,000 | -44.0% | 121,850 | -45.4% | 0.86% | -33.9% |
| Q2 2015 | $3,856,000 | -16.5% | 223,200 | +51.4% | 1.30% | -23.1% |
| Q1 2015 | $4,619,000 | +16.9% | 147,400 | +8.9% | 1.70% | +12.1% |
| Q4 2014 | $3,952,000 | +40.0% | 135,400 | -0.7% | 1.52% | +36.9% |
| Q3 2014 | $2,822,000 | – | 136,400 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |